Patients with IgA vasculitis nephritis achieved remission using immunosuppression therapy

Pediatric patients with IgA vasculitis nephritis and nephrotic-range proteinuria achieved remission after 12 months of mycophenolate mofetil-based immunosuppression treatment, according to data published in Kidney Medicine.
“Currently, there is no consensus on treatment for patients with severe [IgA vasculitis nephritis] IGAVN. Multiple immunosuppressive protocols have been advocated and used with varying results,” Dmitry Samsonov, MD, from the division of nephrology in the department of pediatrics at Maria Fareri Children’s Hospital of New York College in Vahalla, New York,

Pediatric patients with IgA vasculitis nephritis and nephrotic-range proteinuria achieved remission after 12 months of mycophenolate mofetil-based immunosuppression treatment, according to data published in Kidney Medicine.
“Currently, there is no consensus on treatment for patients with severe [IgA vasculitis nephritis] IGAVN. Multiple immunosuppressive protocols have been advocated and used with varying results,” Dmitry Samsonov, MD, from the division of nephrology in the department of pediatrics at Maria Fareri Children’s Hospital of New York College in Vahalla, New York,